Zynyz 500 mg/20 mL (25 mg/mL) injection Images
Generic Name: retifanlimab
This medication has been identified as Zynyz 500 mg/20 mL (25 mg/mL) injection. It is supplied by Incyte Corporation.
Zynyz is used in the treatment of Merkel Cell Carcinoma; Anal Cancer and belongs to the drug class anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors). Zynyz 500 mg/20 mL (25 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Zynyz
- Generic Name
- retifanlimab
- Strength
- 500 mg/20 mL (25 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Incyte Corporation
- National Drug Code (NDC)
- 50881-0006
See also:
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Bavencio
Bavencio (avelumab) is a cancer medicine that interferes with the growth and spread of cancer cells ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Avelumab
Avelumab is used for merkel cell carcinoma, renal cell carcinoma, urothelial carcinoma
Pembrolizumab
Pembrolizumab (Keytruda) is a monoclonal antibody cancer medicine used to treat
More about Zynyz (retifanlimab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.